₹1.85
(Market cap
₹668 Cr
Recently Viewed
Clear AllMarket cap
₹668 Cr
Revenue (TTM)
₹101 Cr
P/E Ratio
37
P/B Ratio
4.3
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹18 Cr
ROE
17.3 %
ROCE
19.5 %
Industry P/E
48.2
EV/EBITDA
18.3
Debt to Equity
0.3
Book Value
₹122
EPS
₹14.1
Face value
10
Shares outstanding
12,837,620
CFO
₹93.40 Cr
EBITDA
₹168.47 Cr
Net Profit
₹114.63 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shree Remedies
| 12.4 | 11.6 | 23.1 | -29.8 | 19.6 | 16.6 | -- |
|
BSE Healthcare
| 2.9 | 4.5 | 8.1 | 6.7 | 25.3 | 14.0 | 11.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Shree Remedies
| -29.6 | -6.5 | 179.1 | -21.9 | 132.2 | 137.7 | 43.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shree Remedies
|
520.7 | 668.4 | 100.5 | 18.1 | 23.3 | 12.1 | 37 | 4.3 |
| 2,494.6 | 20,418.7 | 1,215.1 | 284.8 | 28.7 | 21.1 | 71.2 | 13.4 | |
| 694.9 | 17,224.4 | 5,092.5 | 545.5 | 15.9 | 14.1 | 31.6 | 3.9 | |
| 955.0 | 15,208.2 | 7,918.4 | 429.9 | 10.7 | 7.2 | 35.1 | 2.3 | |
| 1,089.9 | 19,524.8 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 12.5 | 2.2 | |
| 1,831.4 | 20,959.0 | 1,419.3 | 20.1 | 8.4 | 0.5 | 1042.6 | 3.6 | |
| 168.8 | 22,431.1 | 8,871.4 | -223.5 | 1.9 | -1.6 | -- | 2.8 | |
| 958.8 | 15,815.8 | 1,284.3 | 134.4 | -- | 30.7 | 117.7 | 13.0 | |
| 438.0 | 17,644.7 | 3,720.2 | 352.1 | 13.7 | 8.2 | 50.1 | 3.7 | |
| 1,437.5 | 23,412.7 | 3,151.0 | -10.0 | 8.4 | 2.5 | 1064.2 | 5.1 |
No Review & Analysis are available.
--
Incorporated
1995
Chairman
Chandulal Manubhai Kothia
Managing Director
Chandulal Manubhai Kothia
Headquarters
Ankleshwar, Gujarat
Website
Looking for more details about Shree Ganesh Remedies Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsNotice Of Extraordinary General Meeting
13-Mar-2026No News & Announcements are available.
The share price of Shree Ganesh Remedies Ltd is ₹520.65 (BSE) as of 27-Apr-2026 IST. Shree Ganesh Remedies Ltd has given a return of 19.63% in the last 3 years.
The P/E ratio of Shree Ganesh Remedies Ltd is 36.96 times as on 27-Apr-2026, a 23 discount to its peers’ median range of 48.20 times.
The P/B ratio of Shree Ganesh Remedies Ltd is 4.27 times as on 27-Apr-2026, a 20 premium to its peers’ median range of 3.57 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
39.58
|
6.29
|
|
2024
|
30.49
|
7.02
|
|
2023
|
20.56
|
3.58
|
|
2022
|
26.39
|
5.78
|
|
2021
|
28.43
|
6.70
|
The 52-week high and low of Shree Ganesh Remedies Ltd are Rs 794.00 and Rs 381.10 as of 27-Apr-2026.
Shree Ganesh Remedies Ltd has a market capitalisation of ₹ 668 Cr as on 27-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Shree Ganesh Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.